SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cellsOpen Access

Hassan N, Rutsch N, Győrffy B, Espinoza-Sánchez NA, Götte M

Research article (journal) | Peer reviewed

Details about the publication

JournalScientific Reports (Sci. Rep.)
Volume10
Issue1
Page range2262null
StatusPublished
Release year2020 (10/02/2020)
Language in which the publication is writtenEnglish

Authors from the University of Münster

Götte, Martin